{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:39:11Z","timestamp":1781303951229,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Juvenile-onset lupus nephritis (LN) affects up to 80% of juvenile-onset systemic lupus erythematosus patients (JSLE). As the exact role of human renal glomerular endothelial cells (GEnCs) in LN has not been fully elucidated, the aim of this study was to investigate their involvement in LN. Conditionally immortalised human GEnCs (ciGEnCs) were treated with pro-inflammatory cytokines known to be involved in LN pathogenesis and also with LPS. Secretion and surface expression of pro-inflammatory proteins was quantified via ELISA and flow cytometry. NF-\u03ba\u0392 and STAT-1 activation was investigated via immunofluorescence. Serum samples from JSLE patients and from healthy controls were used to treat ciGEnCs to determine via qRT-PCR potential changes in the mRNA levels of pro-inflammatory genes. Our results identified TNF-\u03b1, IL-1\u03b2, IL-13, IFN-\u03b3 and LPS as robust<jats:italic>in vitro<\/jats:italic>stimuli of ciGEnCs. Each of them led to significantly increased production of different pro-inflammatory proteins, including; IL-6, IL-10, MCP-1, sVCAM-1, MIP-1\u03b1, IP-10, GM-CSF, M-CSF, TNF-\u03b1, IFN-\u03b3, VCAM-1, ICAM-1, PD-L1 and ICOS-L. TNF-\u03b1 and IL-1\u03b2 were shown to activate NF-\u03baB, whilst IFN-\u03b3 activated STAT-1. JSLE patient serum promoted IL-6 and IL-1\u03b2 mRNA expression. In conclusion, our<jats:italic>in vitro<\/jats:italic>model provides evidence that human GEnCs play a pivotal role in LN-associated inflammatory process.<\/jats:p>","DOI":"10.1038\/s41598-019-44868-y","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T10:02:39Z","timestamp":1559815359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8436-0676","authenticated-orcid":false,"given":"Paraskevi","family":"Dimou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Budge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Midgley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Satchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Peak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"44868_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nrrheum.2010.121","volume":"6","author":"S Kamphuis","year":"2010","unstructured":"Kamphuis, S. & Silverman, E. D. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nature Reviews Rheumatology 6, 538\u2013546 (2010).","journal-title":"Nature Reviews Rheumatology"},{"key":"44868_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrneph.2012.220","volume":"8","author":"B Sprangers","year":"2012","unstructured":"Sprangers, B., Monahan, M. & Appel, G. B. Diagnosis and treatment of lupus nephritis flares\u2014an update. Nat. Rev. Nephrol. 8, 709\u2013717 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"44868_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson, A. What is damaging the kidney in lupus nephritis? Nature Reviews Rheumatology 12, 143\u2013153 (2016).","journal-title":"Nature Reviews Rheumatology"},{"key":"44868_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1191\/0961203305lu2056oa","volume":"14","author":"EJ Lewis","year":"2005","unstructured":"Lewis, E. J. & Schwartz, M. M. Pathology of lupus nephritis. Lupus 14, 31\u201338 (2005).","journal-title":"Lupus"},{"key":"44868_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pcl.2012.03.007","volume":"59","author":"DM Levy","year":"2012","unstructured":"Levy, D. M. & Kamphuis, S. Systemic Lupus Erythematosus in Children and Adolescents. Pediatric Clinics of North America 59, 345\u2013364 (2012).","journal-title":"Pediatric Clinics of North America"},{"key":"44868_CR6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.rdc.2013.05.001","volume":"39","author":"M Bennett","year":"2013","unstructured":"Bennett, M. & Brunner, H. I. Biomarkers and Updates on Pediatrics Lupus Nephritis. Rheumatic Disease Clinics of North America 39, 833\u2013853 (2013).","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"44868_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF00865490","volume":"8","author":"JS Cameron","year":"1994","unstructured":"Cameron, J. S. Lupus nephritis in childhood and adolescence. Pediatr. Nephrol. 8, 230\u201349 (1994).","journal-title":"Pediatr. Nephrol."},{"key":"44868_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00467-006-0286-0","volume":"22","author":"BS Lee","year":"2007","unstructured":"Lee, B. S. et al. Clinical outcomes of childhood lupus nephritis: a single center\u2019s experience. Pediatr. Nephrol. 22, 222\u201331 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"44868_CR9","first-page":"2635","volume":"29","author":"S Hagelberg","year":"2002","unstructured":"Hagelberg, S. et al. Longterm followup of childhood lupus nephritis. J. Rheumatol. 29, 2635\u20132642 (2002).","journal-title":"J. Rheumatol."},{"key":"44868_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0022-3476(76)80529-X","volume":"89","author":"EH Garin","year":"1976","unstructured":"Garin, E. H., Donnelly, W. H., Fennell, R. S. & Richard, G. A. Nephritis in systemic lupus erythematosus in children. J. Pediatr. 89, 366\u2013371 (1976).","journal-title":"J. Pediatr."},{"key":"44868_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1542\/peds.94.3.335","volume":"94","author":"LY Yang","year":"1994","unstructured":"Yang, L. Y., Chen, W. P. & Lin, C. Y. Lupus nephritis in children\u2013a review of 167 patients. Pediatrics 94, 335\u201340 (1994).","journal-title":"Pediatrics"},{"key":"44868_CR12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1681\/ASN.V76924","volume":"7","author":"N Baqi","year":"1996","unstructured":"Baqi, N. et al. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J. Am. Soc. Nephrol. 7, 924\u20139 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"44868_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/B978-0-12-800102-8.00010-2","volume-title":"Kidney Development, Disease, Repair and Regeneration","author":"Rizaldy P. Scott","year":"2016","unstructured":"Scott, R. P. & Quaggin, S. E. Formation and Maintenance of a Functional Glomerulus. Kidney Development, Disease, Repair and Regeneration, https:\/\/doi.org\/10.1016\/B978-0-12-800102-8.00010-2 (Elsevier Inc., 2016)."},{"key":"44868_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5527\/wjn.v3.i2.16","volume":"3","author":"R Sinha","year":"2014","unstructured":"Sinha, R. & Raut, S. Pediatric lupus nephritis: Management update. World J. Nephrol. 3, 16 (2014).","journal-title":"World J. Nephrol."},{"key":"44868_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1191\/0961203304lu2023oa","volume":"13","author":"MA Dooley","year":"2004","unstructured":"Dooley, M. A., Aranow, C. & Ginzler, E. M. Review of ACR renal criteria in systemic lupus erythematosus. Lupus 13, 857\u2013860 (2004).","journal-title":"Lupus"},{"key":"44868_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/cyto.a.20952","volume":"77","author":"V Mak\u00f3","year":"2010","unstructured":"Mak\u00f3, V. et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1\u03b2, TNF-\u03b1, and LPS. Cytom. Part A 77, 962\u2013970 (2010).","journal-title":"Cytom. Part A"},{"key":"44868_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1756-8722-6-61","volume":"6","author":"J Mai","year":"2013","unstructured":"Mai, J., Virtue, A., Shen, J., Wang, H. & Yang, X.-F. An evolving new paradigm: endothelial cells\u2013conditional innate immune cells. J. Hematol. Oncol. 6, 61 (2013).","journal-title":"J. Hematol. Oncol."},{"key":"44868_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0346-0","volume":"12","author":"SJ O\u2019Carroll","year":"2015","unstructured":"O\u2019Carroll, S. J. et al. Pro-inflammatory TNF\u03b1 and IL-1\u03b2 differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J. Neuroinflammation 12, 131 (2015).","journal-title":"J. Neuroinflammation"},{"key":"44868_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj, A. & Galea, I. The blood-brain barrier in systemic inflammation. Brain, Behavior, and Immunity 60, 1\u201312 (2017).","journal-title":"Brain, Behavior, and Immunity"},{"key":"44868_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2016.06.010","volume":"185","author":"EMD Smith","year":"2017","unstructured":"Smith, E. M. D. & Beresford, M. W. Urinary biomarkers in childhood lupus nephritis. Clin. Immunol. 185, 21\u201331 (2017).","journal-title":"Clin. Immunol."},{"key":"44868_CR21","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1002\/eji.200324270","volume":"33","author":"N Rodig","year":"2003","unstructured":"Rodig, N. et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 33, 3117\u20133126 (2003).","journal-title":"Eur. J. Immunol."},{"key":"44868_CR22","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1038\/sj.onc.1203219","volume":"18","author":"M Karin","year":"1999","unstructured":"Karin, M. How NF-\u03baB is activated: the role of the I\u03baB kinase (IKK) complex. Oncogene 18, 6867\u20136874 (1999).","journal-title":"Oncogene"},{"key":"44868_CR23","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.20161451","volume":"214","author":"MP Rodero","year":"2017","unstructured":"Rodero, M. P. et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J. Exp. Med. 214, 1547\u20131555 (2017).","journal-title":"J. Exp. Med."},{"key":"44868_CR24","doi-asserted-by":"crossref","unstructured":"Watson, L. W. Renal biomarkers in Juvenile-onset Systemic Lupus Erythematosus. (University of Liverpool, 2012).","DOI":"10.1093\/med\/9780199642489.003.0119"},{"key":"44868_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cyto.2012.11.023","volume":"61","author":"M Postal","year":"2013","unstructured":"Postal, M. et al. Th1\/Th2 cytokine profile in childhood-onset systemic lupus erythematosus. Cytokine 61, 785\u2013791 (2013).","journal-title":"Cytokine"},{"key":"44868_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1399-3038.2006.00510.x","volume":"18","author":"NM Heshmat","year":"2007","unstructured":"Heshmat, N. M. & El-Kerdany, T. H. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Pediatr. Allergy Immunol. 18, 346\u2013353 (2007).","journal-title":"Pediatr. Allergy Immunol."},{"issue":"5","key":"44868_CR27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00467-013-2695-1","volume":"29","author":"Mutlu Uysal Yazici","year":"2014","unstructured":"Yazici, M. U., Orhan, D., Kale, G., Besbas, N. & Ozen, S. Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis. Pediatr. Nephrol, https:\/\/doi.org\/10.1007\/s00467-013-2695-1 (2014).","journal-title":"Pediatric Nephrology"},{"key":"44868_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/rheumatology\/kem136","volume":"46","author":"HA Shui","year":"2007","unstructured":"Shui, H. A. et al. LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatology 46, 1277\u20131284 (2007).","journal-title":"Rheumatology"},{"key":"44868_CR29","first-page":"971","volume":"137","author":"T Cavallo","year":"1990","unstructured":"Cavallo, T. & Granholm, N. A. Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB\/W mice. Am. J. Pathol. 137, 971\u20138 (1990).","journal-title":"Am. J. Pathol."},{"key":"44868_CR30","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1007\/s11033-012-1501-7","volume":"39","author":"JX Zhai","year":"2012","unstructured":"Zhai, J. X. et al. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL\/lpr Mice. Mol. Biol. Rep. 39, 6763\u20136771 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"44868_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/01.shk.0000209527.35743.b0","volume":"25","author":"LT Van Eijk","year":"2006","unstructured":"Van Eijk, L. T. et al. Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro. Shock 25, 358\u2013362 (2006).","journal-title":"Shock"},{"key":"44868_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/107999099314234","volume":"19","author":"G Krishnaswamy","year":"1999","unstructured":"Krishnaswamy, G., Kelley, J., Yerra, L., Smith, J. K. & Chi, D. S. Human Endothelium as a Source of Multifunctional Cytokines: Molecular Regulation and Possible Role in Human Disease. J. Interf. Cytokine Res. 19, 91\u2013104 (1999).","journal-title":"J. Interf. Cytokine Res."},{"key":"44868_CR33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4049\/jimmunol.154.2.799","volume":"154","author":"BS Bochner","year":"1995","unstructured":"Bochner, B. S., Klunk, D. A., Sterbinsky, S. A., Coffman, R. L. & Schleimer, R. P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154, 799\u2013803 (1995).","journal-title":"J Immunol"},{"key":"44868_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-1","volume":"7","author":"R Chui","year":"2010","unstructured":"Chui, R. & Dorovini-Zis, K. Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. J Neuroinflammation 7, 1 (2010).","journal-title":"J Neuroinflammation"},{"key":"44868_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0304-3940(94)90450-2","volume":"168","author":"DC Hess","year":"1994","unstructured":"Hess, D. C., Bhutwala, T., Sheppard, J. C., Zhao, W. & Smith, J. ICAM-1 expression on human brain microvascular endothelial cells. Neurosci. Lett. 168, 201\u20134 (1994).","journal-title":"Neurosci. Lett."},{"key":"44868_CR36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/10799900260100114","volume":"22","author":"A Salmaggi","year":"2002","unstructured":"Salmaggi, A. et al. Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J. Interferon Cytokine Res. 22, 631\u2013640 (2002).","journal-title":"J. Interferon Cytokine Res."},{"key":"44868_CR37","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1093\/ndt\/gfn270","volume":"23","author":"SD Marks","year":"2008","unstructured":"Marks, S. D., Williams, S. J., Tullus, K. & Sebire, N. J. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol. Dial. Transplant 23, 3521\u20136 (2008).","journal-title":"Nephrol. Dial. Transplant"},{"key":"44868_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jlb.59.1.61","volume":"59","author":"DN Cook","year":"1996","unstructured":"Cook, D. N. The role of MIP-1\u03b1 in Inflammation and hematopoiesis. J. Leukoc. Biol. 59, 61\u201366 (1996).","journal-title":"J. Leukoc. Biol."},{"issue":"Suppl","key":"44868_CR39","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.1086\/513857","volume":"179","author":"RK Root","year":"1999","unstructured":"Root, R. K. & Dale, D. C. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. J Infect Dis 179(Suppl), S342\u201352 (1999).","journal-title":"J Infect Dis"},{"key":"44868_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0014-5793(88)80766-X","volume":"232","author":"JV Castell","year":"1988","unstructured":"Castell, J. V. et al. Recombinant Human Interleukin-6 (Il-6\/Bsf-2\/Hsf) Regulates The Synthesis of Acute Phase Proteins In Human Hepatocytes. Febs Lett. 232, 347\u2013350 (1988).","journal-title":"Febs Lett."},{"key":"44868_CR41","first-page":"1","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence, T. The Nuclear Factor NF-\u03baB Pathway in Inflammation. About Cold Spring Harbor Perspectives in Biology 1, 1\u201310 (2009).","journal-title":"About Cold Spring Harbor Perspectives in Biology"},{"key":"44868_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"338","author":"AD Luster","year":"1998","unstructured":"Luster, A. D. Chemokines - Chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436\u2013445 (1998).","journal-title":"N. Engl. J. Med."},{"key":"44868_CR43","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1084\/jem.181.3.839","volume":"181","author":"L Llorente","year":"1995","unstructured":"Llorente, L. et al. Role of Interleukin-10 In The B-Lymphocyte Hyperactivity and Autoantibody Production of Human Systemic Lupus-Erythematosus. J. Exp. Med. 181, 839\u2013844 (1995).","journal-title":"J. Exp. Med."},{"key":"44868_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V","volume":"46","author":"ER Stanley","year":"1997","unstructured":"Stanley, E. R. et al. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46, 4\u201310 (1997).","journal-title":"Mol. Reprod. Dev."},{"key":"44868_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon- y: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163\u2013189 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"44868_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/00062752-200005000-00009","volume":"7","author":"HU Zeilhofer","year":"2000","unstructured":"Zeilhofer, H. U. & Schorr, W. Role of interleukin-8 in neutrophil signaling. Current Opinion in Hematology 7, 178\u2013182 (2000).","journal-title":"Current Opinion in Hematology"},{"key":"44868_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1742-1241.2007.01330.x","volume":"61","author":"DJ Preiss","year":"2007","unstructured":"Preiss, D. J. & Sattar, N. Vascular cell adhesion molecule-1: A viable therapeutic target for atherosclerosis? International Journal of Clinical Practice 61, 697\u2013701 (2007).","journal-title":"International Journal of Clinical Practice"},{"key":"44868_CR48","doi-asserted-by":"publisher","first-page":"H926","DOI":"10.1152\/ajpheart.00779.2008","volume":"295","author":"PG Frank","year":"2008","unstructured":"Frank, P. G. & Lisanti, M. P. ICAM-1: role in inflammation and in the regulation of vascular permeability. Am. J. Physiol. - Hear. Circ. Physiol. 295, H926\u2013H927 (2008).","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"44868_CR49","doi-asserted-by":"publisher","first-page":"C767","DOI":"10.1152\/ajpcell.1992.263.4.C767","volume":"263","author":"CL Myers","year":"1992","unstructured":"Myers, C. L., Wertheimer, S. J., Schembri-King, J., Parks, T. & Wallace, R. W. Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC. Am. J. Physiol. 263, C767\u2013C772 (1992).","journal-title":"Am. J. Physiol."},{"key":"44868_CR50","doi-asserted-by":"publisher","unstructured":"Scott, D. W., Vallejo, M. O. & Patel, R. P. Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of origin. J. Am. Heart Assoc, https:\/\/doi.org\/10.1161\/JAHA.113.000263 (2013).","DOI":"10.1161\/JAHA.113.000263"},{"key":"44868_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02739","volume":"9","author":"SL Maas","year":"2018","unstructured":"Maas, S. L., Soehnlein, O. & Viola, J. R. Organ-Specific Mechanisms of Transendothelial Neutrophil Migration in the Lung, Liver, Kidney, and Aorta. Front. Immunol. 9, 1\u201324 (2018).","journal-title":"Front. Immunol."},{"issue":"11","key":"44868_CR52","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.4049\/jimmunol.176.11.6991","volume":"176","author":"M. P. Kuligowski","year":"2006","unstructured":"Kuligowski, M. P., Kitching, A. R. & Hickey, M. J. Leukocyte Recruitment to the Inflamed Glomerulus: A Critical Role for Platelet-Derived P-Selectin in the Absence of Rolling. J. Immunol, https:\/\/doi.org\/10.4049\/jimmunol.176.11.6991 (2006).","journal-title":"The Journal of Immunology"},{"issue":"8","key":"44868_CR53","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/rheumatology\/40.8.889","volume":"40","author":"O. A. Harari","year":"2001","unstructured":"Harari, O. A., Marshall, D., McHale, J. F., Ahmed, S. & Haskard, D. O. Limited endothelial E- and P-selectin expression in MRL\/lpr lupus-prone mice. Rheumatology, https:\/\/doi.org\/10.1093\/rheumatology\/40.8.889 (2001).","journal-title":"Rheumatology"},{"issue":"3","key":"44868_CR54","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2353\/ajpath.2010.091143","volume":"177","author":"Sapna Devi","year":"2010","unstructured":"Devi, S. et al. Platelet recruitment to the inflamed glomerulus occurs via an \u03b1IIb\u03b23\/GPVI-dependent pathway. Am. J. Pathol, https:\/\/doi.org\/10.2353\/ajpath.2010.091143 (2010).","journal-title":"The American Journal of Pathology"},{"key":"44868_CR55","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/ndt\/12.6.1122","volume":"12","author":"IA Hauser","year":"1997","unstructured":"Hauser, I. A., Riess, R., Hausknecht, B., Th\u00fcringer, H. & Sterzel, R. B. Expression of cell adhesion molecules in primary renal disease and renal allograft rejection. Nephrol. Dial. Transplant. 12, 1122\u20131131 (1997).","journal-title":"Nephrol. Dial. Transplant."},{"key":"44868_CR56","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.4049\/jimmunol.170.7.3637","volume":"170","author":"N Selenko-Gebauer","year":"2003","unstructured":"Selenko-Gebauer, N. et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170, 3637\u20133644 (2003).","journal-title":"J. Immunol."},{"key":"44868_CR57","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1073\/pnas.092576699","volume":"99","author":"S Khayyamian","year":"2002","unstructured":"Khayyamian, S. et al. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc. Natl. Acad. Sci. USA 99, 6198\u20136203 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"44868_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.184.1.173","volume":"184","author":"K Karmann","year":"1996","unstructured":"Karmann, K., Min, W., Fanslow, W. C. & Pober, J. S. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J. Exp. Med. 184, 173\u201382 (1996).","journal-title":"J. Exp. Med."},{"issue":"7","key":"44868_CR59","doi-asserted-by":"publisher","first-page":"e21589","DOI":"10.1371\/journal.pone.0021589","volume":"6","author":"Martine Perrot-Applanat","year":"2011","unstructured":"Perrot-Applanat, M. et al. Similar NF-\u03baB gene signatures in TNF-\u03b1 treated human endothelial cells and breast tumor biopsies. PLoS One 6 (2011).","journal-title":"PLoS ONE"},{"issue":"3","key":"44868_CR60","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cardiores.2007.02.030","volume":"74","author":"Y TSAI","year":"2007","unstructured":"Tsai, Y. C. et al. Laminar flow attenuates interferon-induced inflammatory responses in endothelial cells. Cardiovasc. Res, https:\/\/doi.org\/10.1016\/j.cardiores.2007.02.030 (2007).","journal-title":"Cardiovascular Research"},{"key":"44868_CR61","doi-asserted-by":"crossref","unstructured":"Carvalho, D., Savage, C. O. S., Isenberg, D. & Pearson, J. D. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocr. Arthritis Rheum, doi:10.1002\/1529-0131(199904)42:4<631::AID-ANR5>3.0.CO;2-X (1999).","DOI":"10.1002\/1529-0131(199904)42:4<631::AID-ANR5>3.0.CO;2-X"},{"issue":"6","key":"44868_CR62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/096120339900800603","volume":"8","author":"N Del Papa","year":"1999","unstructured":"Papa, N. D et al. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro. Lupus, https:\/\/doi.org\/10.1177\/096120339900800603 (1999).","journal-title":"Lupus"},{"issue":"1","key":"44868_CR63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1172\/JCI118377","volume":"97","author":"D Carvalho","year":"1996","unstructured":"Carvalho, D., Savage, C. O. S., Black, C. M. & Pearson, J. D. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro: Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J. Clin. Invest, https:\/\/doi.org\/10.1172\/JCI118377 (1996).","journal-title":"Journal of Clinical Investigation"},{"key":"44868_CR64","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.ki.5000277","volume":"69","author":"SC Satchell","year":"2006","unstructured":"Satchell, S. C. et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 69, 1633\u20131640 (2006).","journal-title":"Kidney Int."},{"issue":"40","key":"44868_CR65","doi-asserted-by":"publisher","first-page":"28808","DOI":"10.1074\/jbc.274.40.28808","volume":"274","author":"Katsuhiro Zen","year":"1999","unstructured":"Zen, K. et al. NF-\u03baB activation is required for human endothelial survival during exposure to tumor necrosis factor-\u03b1 but not to interleukin-1\u03b2 or lipopolysaccharide. J. Biol. Chem, https:\/\/doi.org\/10.1074\/jbc.274.40.28808 (1999).","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"44868_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/10496470801946133","volume":"13","author":"Shaza M. Al-Massarany","year":"2008","unstructured":"Malavia, N. K., Mih, J. D., Raub, C. B., Dinh, B. T. & George, S. C. IL-13 induces a bronchial epithelial phenotype that is profibrotic. Respir. Res, https:\/\/doi.org\/10.1080\/10496470801946133 (2008).","journal-title":"Journal of Herbs, Spices & Medicinal Plants"},{"key":"44868_CR67","doi-asserted-by":"crossref","unstructured":"Melrose, J., Tsurushita, N., Liu, G. & Berg, E. L. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. J. Immunol. (1998).","DOI":"10.4049\/jimmunol.161.5.2457"},{"key":"44868_CR68","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nature Methods 9, 676\u2013682 (2012).","journal-title":"Nature Methods"},{"key":"44868_CR69","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1191\/096120398678920172","volume":"7","author":"Y Ikeda","year":"1998","unstructured":"Ikeda, Y., Fujimoto, T., Ameno, M., Shiiki, H. & Dohi, K. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Lupus 7, 347\u2013354 (1998).","journal-title":"Lupus"},{"key":"44868_CR70","first-page":"189","volume":"54","author":"S Pizarro","year":"2007","unstructured":"Pizarro, S., Espino, J. M., Ruiz, A. & Jara, L. J. Soluble vascular cell adhesion molecule-1 indicates SLE disease activity and specific organ involvement. Rev. Alerg. M\u00e9xico 54, 189\u2013195 (2007).","journal-title":"Rev. Alerg. M\u00e9xico"},{"key":"44868_CR71","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1191\/096120300678828749","volume":"9","author":"K Egerer","year":"2000","unstructured":"Egerer, K. et al. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 9, 614\u2013621 (2000).","journal-title":"Lupus"},{"key":"44868_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000045663","volume":"85","author":"CY Tsai","year":"2000","unstructured":"Tsai, C. Y., Wu, T. H., Yu, C. L., Lu, J. Y. & Tsai, Y. Y. Increased excretions of beta(2)-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron 85, 207\u2013214 (2000).","journal-title":"Nephron"},{"key":"44868_CR73","doi-asserted-by":"crossref","unstructured":"Cavalcanti, A., Santos, R., Mesquita, Z., Duarte, A. L. B. P. & Lucena-Silva, N. Cytokine profile in childhood-onset systemic lupus erythematosus: A cross-sectional and longitudinal study. Brazilian J. Med. Biol. Res. 50 (2017).","DOI":"10.1590\/1414-431x20175738"},{"key":"44868_CR74","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00011-007-6147-x","volume":"56","author":"S Tian","year":"2007","unstructured":"Tian, S. et al. Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare. Inflamm. Res. 56, 304\u2013310 (2007).","journal-title":"Inflamm. Res."},{"key":"44868_CR75","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1681\/ASN.2013121356","volume":"26","author":"J Menke","year":"2015","unstructured":"Menke, J. et al. Colony-Stimulating Factor-1: A Potential Biomarker for Lupus Nephritis. J. Am. Soc. Nephrol. 26, 379\u2013389 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"44868_CR76","first-page":"26","volume":"1","author":"J Frank","year":"1993","unstructured":"Frank, J., Engler-Blum, G., Rodemann, H. P. & M\u00fcller, G. A. Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp. Nephrol. 1, 26\u201335 (1993).","journal-title":"Exp. Nephrol."},{"key":"44868_CR77","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1046\/j.1523-1755.1999.00646.x","volume":"56","author":"T Wada","year":"1999","unstructured":"Wada, T. et al. MIP-1\u03b1 and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int. 56, 995\u20131003 (1999).","journal-title":"Kidney Int."},{"key":"44868_CR78","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1006\/cyto.2000.0757","volume":"12","author":"S Narumi","year":"2000","unstructured":"Narumi, S., Takeuchi, T., Kobayashi, Y. & Konishi, K. Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus. Cytokine 12, 1561\u20131565 (2000).","journal-title":"Cytokine"},{"issue":"3","key":"44868_CR79","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejr.2012.05.003","volume":"34","author":"Ghada S. Azkalany","year":"2012","unstructured":"Azkalany, G. S., Gheita, T. A., Gaber, W. & Mohey, A. Clinical significance of serum TNF\u03b1 and \u2212308 G\/A promoter polymorphism and serum Il-6 and \u2212174 G\/C promoter polymorphism in systemic lupus erythematosus patients. Egypt. Rheumatol, https:\/\/doi.org\/10.1016\/j.ejr.2012.05.003 (2012).","journal-title":"The Egyptian Rheumatologist"},{"key":"44868_CR80","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1186\/1546-0096-10-S1-A2","volume":"10","author":"AM Stevens","year":"2012","unstructured":"Stevens, A. M. & Ou, J.-N. PD-L1 expression on monocytes marks active systemic lupus erythematosus in patients without nephritis. Pediatr. Rheumatol. 10, A2 (2012).","journal-title":"Pediatr. Rheumatol."},{"key":"44868_CR81","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0961203308099176","volume":"18","author":"M Her","year":"2009","unstructured":"Her, M., Kim, D., Oh, M., Jeong, H. & Choi, I. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus. Lupus 18, 501\u2013507 (2009).","journal-title":"Lupus"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44868-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T07:06:31Z","timestamp":1694934391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44868-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44868"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44868-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8348"}}